EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy of fludrocortisone for symptom relief in patients with autonomic syncope and hypotensive phenotype

Rose Anne Kenny iD, Ciara Rice, Vincenzo Russo iD, Erika Parente iD, Frederik J De Lange iD, Thomas T Boel iD, Antonella Groppelli iD, Jean Claude Deharo iD, Baptiste Maille iD, Artur Fedorowski iD, Maria Juszczyk, Roberto Maggi iD und 4 weitere

Europace · 03.11.2026

DOI: 10.1093/europace/euag304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, online erschienen am 03.11.2026. Verfasst von Rose Anne Kenny und 15 weiteren Autor:innen. Beteiligte Einrichtung: Falls and Syncope Unit, St James Hospital and Trinity College, Dublin, Ireland. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess the efficacy of fludrocortisone therapy in patients with autonomic syncope and hypotensive phenotype Methods and results Multicentre, prospective, non-randomized study. Fludrocortisone therapy was guided by clinician experience and supported by two 24-hour ambulatory blood pressure monitoring (ABPM) assessments—one before treatment start (ABPM 1) and one after drug optimization (ABPM 2). Primary endpoint: reduction of the syncope burden and presyncopal symptoms based on validated semi structured questionnaires. Secondary endpoint: hypotensive episodes on ABPM. In a cohort of 94 patients treated with fludrocortisone (median age 38 [IQR 21-57]) years, 83% females), 16 patients stopped therapy due to side effects, occurring during optimization (#11) or follow-up (#5). A total of 83 patients were analysed. The average 24-hour systolic blood pressure (SBP) increased from 106.3 ± 8.2 mmHg at ABPM 1 to 112.3 ± 9.3 at ABPM 2 (p = 0.0001). The number of daytime SBP drops <90 mmHg and <100 mmHg decreased by 61%, and 45% respectively (p < 0.001 for both). The annual syncope burden was reduced by 50.2%, from 2.0 (IQR 1.0-4.0) before therapy to 0.0 (IQR 0.0–1.8) episodes during a median follow-up of 12.9 months (p = 0.0001). Subjective symptom improvement was reported by 85.6% of patients. The frequency of syncope/presyncope decreased significantly, p = 0.009. The outcome was similar in 42 younger (23 ± 6 yrs) and in 41 older (56 ± 12 yrs) patients.

Conclusion

Fludrocortisone therapy was associated with reduced hypotension and the burden of symptoms both in younger and in older patients. Side effects lead to discontinuation of therapy in 17% of cases.

Autor:innen und Institutionen

  • Falls and Syncope Unit, St James Hospital and Trinity College, Dublin, Ireland.
  • Department of Translational Medical Sciences, Cardiology and Syncope Unit, University of Campania 'Luigi Vanvitelli'-Monaldi Hospital, Piazzale E. Ruggeri, Naples 80126, Italy; Naples.
  • Amsterdam University Medical Centre, University of Amsterdam, Heart Centre, Department of Clinical and Experimental Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Cardiology, IRCCS Istituto Auxologico Italiano, Faint and Fall Research Centre, S. Luca Hospital, Piazzale Brescia 20, Milano 20149, Italy.
  • Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie, France and Aix Marseille Université, C2VN, Marseille 13005, France.
  • Department of Cardiology, Karolinska University Hospital, and Department of Medicine, Karolinska Institute, Stockholm, Sweden.

ORCID-Profile: Rose Anne Kenny, Vincenzo Russo, Erika Parente, Frederik J De Lange, Thomas T Boel, Antonella Groppelli, Jean Claude Deharo, Baptiste Maille, Artur Fedorowski, Roberto Maggi, Jaume Francisco-Pascual, Giulia Rivasi, Michele Brignole

Zitieren

APA

Kenny, R. A., Rice, C., Russo, V., Parente, E., De Lange, F. J., Boel, T. T., Groppelli, A., Deharo, J. C., Maille, B., Fedorowski, A., Juszczyk, M., Maggi, R., Francisco-Pascual, J., Rivasi, G., Laffi, M., & Brignole, M. (2026). Efficacy of fludrocortisone for symptom relief in patients with autonomic syncope and hypotensive phenotype. Europace. https://doi.org/10.1093/europace/euag304

Vancouver

Kenny RA, Rice C, Russo V, Parente E, De Lange FJ, Boel TT, et al. Efficacy of fludrocortisone for symptom relief in patients with autonomic syncope and hypotensive phenotype. Europace. 2026. doi:10.1093/europace/euag304

BibTeX
@article{Kenny2026,
  author = {Kenny, Rose Anne and Rice, Ciara and Russo, Vincenzo and Parente, Erika and De Lange, Frederik J and Boel, Thomas T and Groppelli, Antonella and Deharo, Jean Claude and Maille, Baptiste and Fedorowski, Artur and Juszczyk, Maria and Maggi, Roberto and Francisco-Pascual, Jaume and Rivasi, Giulia and Laffi, Mattia and Brignole, Michele},
  title = {Efficacy of fludrocortisone for symptom relief in patients with autonomic syncope and hypotensive phenotype},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag304}
}
Kostenlos starten →